Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences High Content & Phenotypic Screening 2016

Leo Price's Biography



Leo Price, CEO, Ocello B.V

Leo Price was trained as a cell biologist and has held positions in London, San Diego, Amsterdam and Utrecht in cancer research. From 2005, he ran a research group at Leiden University, where he developed 3D tissue culture based screening technology. This technology was spun off as OcellO, a contract research company that develops physiologically relevant models of disease and uses these to offer compound screening and profiling services for the drug discovery industry.

Leo Price Image

Screening and Profiling of Cancer Therapeutics in Primary and Stem Cell-derived Human 3D Tissues

Tuesday, 10 May 2016 at 14:15

Add to Calendar ▼2016-05-10 14:15:002016-05-10 15:15:00Europe/LondonScreening and Profiling of Cancer Therapeutics in Primary and Stem Cell-derived Human 3D TissuesHigh Content and Phenotypic Screening 2016 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com

We describe the combination of 3D culture of human tissues with ultra-high content 3D image analysis to screen compound libraries and identify and profile novel cancer therapeutics.


Add to Calendar ▼2016-05-10 00:00:002016-05-11 00:00:00Europe/LondonHigh Content and Phenotypic Screening 2016High Content and Phenotypic Screening 2016 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com